MarketScreener Editorial Features Avacta Group Plc
Equities
AVCT
GB00BYYW9G87
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.50 GBX | 0.00% |
|
-0.83% | +2.59% |
| 09/02 | Avacta appoints new chief scientific officer, plans clinical trials | AN |
| 09/02 | Avacta Therapeutics Names Chemistry Vice President as Chief Scientific Officer | MT |
MarketScreener Editorial Features
Search
No results for this search
- Stock Market
- Equities
- AVCT Stock
- News Avacta Group Plc
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition